Pembrolizumab Is Effective for Drug-Resistant Gestational Trophoblastic Neoplasia
The Lancet - United Kingdom
doi 10.1016/s0140-6736(17)32894-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2017
Authors
Publisher
Elsevier BV